Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Composition : Mirabegron 50mg + Solifenacine Succinate I.P. 5mg
Dosage Form : Tablet
Packaging Type : Alu-Alu
Packaging : 10x10
Price : ₹1/-
Miratyle S 50/5 Tablet is a combination of Mirabegron (50mg) and Solifenacin Succinate I.P. (5mg), formulated to provide comprehensive management of overactive bladder (OAB) symptoms. Mirabegron, a beta-3 adrenergic agonist, enhances bladder storage capacity by relaxing the detrusor muscle during the storage phase. Solifenacin Succinate, a muscarinic receptor antagonist, reduces involuntary bladder contractions and urgency. Together, these components synergistically alleviate urinary frequency, urgency, and urge incontinence, offering a dual mechanism of action for better symptom control and improved patient compliance.
This dual-action therapy is ideal for patients who experience insufficient symptom relief with monotherapy or who need a broader therapeutic approach to manage OAB. The tablet is designed for once-daily administration, providing convenience and sustained relief throughout the day.
Common side effects may include dry mouth, constipation, increased blood pressure, headache, and dizziness.
For the treatment of overactive bladder (OAB) symptoms, including urinary urgency, increased frequency, and urge incontinence.
Use only under medical supervision. Avoid in patients with severe liver or kidney impairment or uncontrolled hypertension.
Composition : Tolperisone (150mg) + Paracetamol (325mg)
Composition : Tolperisone (450mg) + Diclofenac (100mg)
Composition : Tolperisone (150mg) + Diclofenac (50mg)
Composition : Tranexamic Acid (500mg)
Composition : Thiocolchicoside (4mg) + Aceclofenac (100mg) + Paracetamol (325mg)
Composition : Trypsin I.P. 48mg + Bromelain B.P. 90mg + Rutoside Trihydrate B.P. 100mg + Diclofenac I.P. 50mg
Composition : Tamsulosin (0.4mg) + Dutasteride (0.5mg)